Immunogenicity of COVID-19 vaccines in patients with diabetes mellitus: A systematic review

Overview of attention for article published in Frontiers in immunology, August 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (56th percentile)
Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

twitter: 7 X users

Readers on

mendeley: 47 Mendeley

Summary X

So far, Altmetric has seen 8 X posts from 7 X users, with an upper bound of 102,939 followers.

RT @COVID_Evidence: PubMed: Immunogenicity of COVID-19 vaccines in patients with diabetes mellitus: A systematic review: CONCLUSION: Immun…

16 Sep 2022

Reply Repost Favourite

PubMed: Immunogenicity of COVID-19 vaccines in patients with diabetes mellitus: A systematic review: CONCLUSION: Immunogenicity of the vaccines has mostly been reported to be lower among patients with DM compared to… https://t.co/reazULMiMy #covid19 #SARS

15 Sep 2022

Reply Repost Favourite

RT @DrImranSheikh: Immunogenicity of COVID-19 vaccines in patients with diabetes mellitus: A systematic review: Purpose To evaluate the imm…

31 Aug 2022

Reply Repost Favourite

Immunogenicity of COVID-19 vaccines in patients with diabetes mellitus: A systematic review: Purpose To evaluate the immunogenicity of COVID-19 vaccines in patients with diabetes mellitus (DM) through a systematic… #immunology https://t.co/aObtYNGDhx https

31 Aug 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 4 additional X posts.